<DOC>
	<DOC>NCT00074854</DOC>
	<brief_summary>The purpose of this study is to determine whether CP-547,632, an oral VEGFR-2 tyrosine kinase inhibitor when given in combination with chemotherapy (carboplatin and paclitaxel) is effective in the treatment of advanced stage non-small cell lung cancer.</brief_summary>
	<brief_title>A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Histologically or cytologically confirmed stage IIIB (inicluding those with pleural effusion), IV or recurrent nonsmall cell lung cancer (nsclc). Bidimensionally measurable disease &gt;2cm x 1 cm by conventional CT Scan or &gt;1 cm x 1cm by spiral CT Scan. No tumors in close proximity to major veins or arteries. No sanguinous pleural effusion due to disease or pericardial effusion suspicious for disease. No evidence or history brain metastases.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>